Cargando…
Delivery of anti-microRNA-21 by lung-targeted liposomes for pulmonary fibrosis treatment
Idiopathic pulmonary fibrosis (IPF) is a chronic lung disorder with a low survival rate. Pulmonary fibrosis is one of the complications of COVID-19 and has a high prevalence in COVID-19 patients. Currently, no effective therapies other than lung transplantation are available to cure IPF and post-COV...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society of Gene & Cell Therapy
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972768/ https://www.ncbi.nlm.nih.gov/pubmed/36919116 http://dx.doi.org/10.1016/j.omtn.2023.02.031 |